Migraine treatment improved considerably with the advent of the 'triptans' in the 1990s. While the drugs used previously for headache treatment had efficacy, some compounds had bothersome side effects and their overuse could lead to severe complications. In the early days of the triptans, it was widely presumed that migraine was no longer a treatment problem. However, it has gradually been recognized that a significant proportion of patients are not responsive to triptans or do not tolerate them. It is now clear that, even ...
Read More
Migraine treatment improved considerably with the advent of the 'triptans' in the 1990s. While the drugs used previously for headache treatment had efficacy, some compounds had bothersome side effects and their overuse could lead to severe complications. In the early days of the triptans, it was widely presumed that migraine was no longer a treatment problem. However, it has gradually been recognized that a significant proportion of patients are not responsive to triptans or do not tolerate them. It is now clear that, even with effective treatment, patients with frequent migraine attacks are not treated well exclusively with acute medications. This is partly because patients are still bothered by the attacks and partly because frequent intake of acute medication may result in medication-overuse headache. These problems have led to a renewed interest in preventive migraine drugs. Part of the Frontiers in Headache Research series, this book summarizes the several promising new avenues for the development of future drugs for the treatment of migraine, including cortical-spreading depression inhibition, nitric oxide synthase inhibition and calcitonin gene-related peptide (CGRP) receptor antagonism, as well as other potential targets. The book presents frontline knowledge of these evolving modalities as far as it is available in the public domain. It is hoped that readers and their patients will find it exciting to learn about all the novel possibilities, and also that the impressive research advances in migraine will lead to increased funding, not only of migraine but also of other types of headache.
Read Less
Add this copy of Innovative Drug Development for Headache Disorders to cart. $245.31, new condition, Sold by Books2anywhere rated 5.0 out of 5 stars, ships from Fairford, GLOUCESTERSHIRE, UNITED KINGDOM, published 2008 by Oxford University Press.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
PLEASE NOTE, WE DO NOT SHIP TO DENMARK. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Please note we cannot offer an expedited shipping service from the UK.
Add this copy of Innovative Drug Development for Headache Disorders to cart. $292.57, new condition, Sold by Kennys.ie rated 4.0 out of 5 stars, ships from Galway, IRELAND, published 2008 by Oxford University Press.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
New. This latest volume of the Frontiers in Headache Research series summarizes the several promising new avenues for the development of future drugs for the treatment of migraine. Editor(s): Olesen, Jes; Ramadan, Nabih M. Series: Frontiers in Headache Research Series. Num Pages: 230 pages, 50 black and white line drawings and 6 images. BIC Classification: MJN. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 254 x 177 x 18. Weight in Grams: 569. 2008. Hardback.....We ship daily from our Bookshop.
Add this copy of Innovative Drug Development for Headache Disorders to cart. $16.47, like new condition, Sold by Poverty Hill Books rated 5.0 out of 5 stars, ships from Mt. Prospect, IL, UNITED STATES, published 2008 by Oxford University Press.
Add this copy of Innovative Drug Development for Headache Disorders to cart. $101.85, new condition, Sold by Basi6 International rated 5.0 out of 5 stars, ships from Irving, TX, UNITED STATES, published 2008 by Oxford University Press.
Add this copy of Innovative Drug Development for Headache Disorders to cart. $101.85, new condition, Sold by discount_scientific_books rated 5.0 out of 5 stars, ships from Sterling Heights, MI, UNITED STATES, published 2008 by Oxford University Press.
Add this copy of Innovative Drug Development for Headache Disorders to cart. $102.85, new condition, Sold by Basi6 International rated 5.0 out of 5 stars, ships from Irving, TX, UNITED STATES, published 2008 by Oxford University Press.
Add this copy of Innovative Drug Development for Headache to cart. $105.11, new condition, Sold by Basi6 International rated 5.0 out of 5 stars, ships from Irving, TX, UNITED STATES, published 2008 by Oxford University Press.
